have higher expense ratios than do biotech ETFs. The largest biotech mutual fund in terms of assets is Fidelity Select Biotechnology FBIOX , which charges 0.86%. Another possibility is Rydex Biotechnology RYOIX (1.39%). For broader
FBIOX was down today. 7 of the top 10 holdings were down! Anyone know why? Tom
biotech names. The fund's portfolio is concentrated. A shifting health-care landscape may not trip up Fidelity Select Biotechnology too badly, but the fund is hardly home free. While health-care reform may lead to some unforeseeable
shown a willingness to invest beyond the largest biotech names. The fund's portfolio is concentrated. Fidelity Select Biotechnology wasn't its usual self in 2009, but that's not a reason to count it out. Following the early 2000s
IDEC and Elan also highlighted the even greater risks associated with owning concentrated sector funds, which most investors simply don't need. For instance, Fidelity Select Biotechnology FBIOX lost 10.76% of its value in a single day.
fund's combination of risk and reserve hasn't been appealing. No one should be shocked to learn that Fidelity Select Biotechnology Portfolio is risky. After all, its name is a giveaway. But as biotech-dedicated offerings go, this
companies. Yolanda Strock came on the job in June 2000, after working on other Fidelity Select funds, including Biotechnology FBIOX , Banking FSRBX, and Construction & Housing FSHOX. She's backed by Fidelity's team of analysts. SpecialtySpecialty
1991, when the sector was all the rage, Fidelity Select Biotechnology FBIOX was the third best performing offering ..... the wind at his back since he started. Fidelity Select Biotechnology FBIOX : The granddaddy of biotech funds, this
slots for the month through August 25 were held by biotechnology offerings Rydex Biotechnology RYOAX , Fidelity Select Biotechnology FBIOX , and Franklin Biotechnology Discovery FBDIX , all up between 14% and 18% for the past four weeks alone
close to becoming tulips. If you want to see what happens when bubbles burst, check out the returns of Fidelity Select Biotechnology . In the early '90s anything with "bio" or "med" in its name was granted an amazing value. The frenzy